FFO
IRON icon

Fortitude Family Office’s Disc Medicine IRON Stock Holding History

Fortitude Family Office’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73 Buy
+1
New +$69 ﹤0.01% 2185
2025
Q2 		– Sell
-20
Closed -$993 – 2077
2025
Q1 		$993 Hold
20
– – ﹤0.01% 1014
2024
Q4 		$1.27K Buy
+20
New +$1.16K ﹤0.01% 1101
2024
Q2 		– Sell
-356
Closed -$22.2K – 1017
2024
Q1 		$22.2K Buy
356
+132
+59% +$8.56K 0.01% 262
2023
Q4 		$12.9K Buy
+224
New +$11.5K 0.01% 371

Other funds holding IRON

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
EC
Eleva Capital Paris, France $343M AUM
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Fortitude Family Office's IRON Position: Q2 2026 in Review

Fortitude Family Office opened a new position in Disc Medicine (IRON) in Q2 2026: 1 share worth $73. The stake represents ﹤0.01% of the portfolio and ranks #2185 among its holdings. This is a return to the name: Fortitude Family Office previously reported a position in IRON as recently as Q1 2025.

Fortitude Family Office first reported a position in IRON in Q4 2023 and has held it in 5 quarters since. The position peaked at $22.2K in Q1 2024. 21 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Fortitude Family Office held 1 share of Disc Medicine worth $73 as of Q2 2026.
  • Disc Medicine was a new Fortitude Family Office position in Q2 2026.
  • Disc Medicine made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #2185 holding.
  • Fortitude Family Office first reported a position in Disc Medicine in Q4 2023 and has held it in 5 quarters since.
  • Fortitude Family Office's Disc Medicine position peaked at $22.2K in Q1 2024.
  • 21 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.